The effect of dezocine on postoperative catheter-related bladder discomfort in patients undergoing transurethral bladder tumour resection: A double-blind randomised study

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR1900027814

Enrollment

Unknown

Registered

2019-11-29

Start date

2019-12-01

Completion date

Unknown

Last updated

2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

CRBD

Interventions

Experimental group:dezocine

Control group:0.9% N.S. 2 ml

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: patients undergoing transurethral bladder tumour resection

Exclusion criteria

Exclusion criteria: Bladder outflow obstruction, overactive bladder (frequency greater than three times per night or more than eight times per 24 h), end-stage renal disease,neurogenic bladder, heart failure, arrhythmia, morbid obesity, use of chronic analgesic medication and hepatic or psychiatric disease.

Design outcomes

Primary

Measure	Time frame
postoperative catheter-related bladder discomfort;	—

Countries

China

Contacts

Public ContactCui Yuanshan

Beijing Tiantan Hospital, Capital Medical University

doctorcuiys@163.com+86 15684091897

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026